Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$127,561
in 3 filings, $17K under 10b5-1 plans

Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-01 Pinion John Richard See Remarks Grant or award +4,636 56,435
2021-03-01 Pinion John Richard See Remarks Sale −6,198 $138.17 $856K 50,237
2021-03-01 Pinion John Richard See Remarks Grant or award · Stock Option (Right to Buy) +11,000 11,000
2021-03-01 Parschauer Karah Herdman EVP and General Counsel Grant or award +5,500 29,561
2021-03-01 Parschauer Karah Herdman EVP and General Counsel Grant or award +4,636 34,197
2021-03-01 Parschauer Karah Herdman EVP and General Counsel Sale −3,970 $138.17 $549K 30,227
2021-03-01 Parschauer Karah Herdman EVP and General Counsel Grant or award · Stock Option (Right to Buy) +11,000 11,000
2021-03-01 Huizenga Theodore Alan SVP, Controller and PAO Grant or award +1,560 17,276
2021-03-01 Huizenga Theodore Alan SVP, Controller and PAO Sale −732 $138.17 $101K 16,544
2021-03-01 Huizenga Theodore Alan SVP, Controller and PAO Grant or award · Stock Option (Right to Buy) +4,655 4,655

Page 21 of 21 · 410 trades